RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 100 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $53,000 | -39.1% | 22,439 | -42.7% | 0.00% | -50.0% |
| Q2 2016 | $87,000 | +210.7% | 39,160 | +190.3% | 0.00% | +100.0% |
| Q1 2016 | $28,000 | -78.0% | 13,490 | -67.9% | 0.00% | -50.0% |
| Q4 2015 | $127,000 | -32.4% | 42,021 | -44.9% | 0.00% | -33.3% |
| Q3 2015 | $188,000 | +118.6% | 76,300 | +216.6% | 0.00% | +50.0% |
| Q1 2015 | $86,000 | +68.6% | 24,100 | +7.8% | 0.00% | +100.0% |
| Q4 2014 | $51,000 | +41.7% | 22,346 | +21.6% | 0.00% | 0.0% |
| Q3 2014 | $36,000 | -81.7% | 18,378 | -66.3% | 0.00% | -66.7% |
| Q2 2014 | $197,000 | +50.4% | 54,475 | +61.5% | 0.00% | +50.0% |
| Q1 2014 | $131,000 | +59.8% | 33,728 | +16.1% | 0.00% | +100.0% |
| Q4 2013 | $82,000 | -34.4% | 29,049 | -16.9% | 0.00% | -50.0% |
| Q3 2013 | $125,000 | – | 34,976 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,020,719 | $3,746,000 | 2.58% |
| Boxer Capital, LLC | 1,351,137 | $4,959,000 | 2.22% |
| Palo Alto Investors LP | 5,186,088 | $19,033,000 | 1.11% |
| DAFNA Capital Management LLC | 340,000 | $1,248,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 907,203 | $3,329,435,000 | 0.86% |
| Rhenman & Partners Asset Management AB | 1,400,000 | $5,138,000,000 | 0.82% |
| NEA Management Company, LLC | 3,243,150 | $11,902,000 | 0.53% |
| Cormorant Asset Management, LP | 1,155,600 | $4,241,000 | 0.47% |
| Ghost Tree Capital, LLC | 700,000 | $2,569,000 | 0.42% |
| Rock Springs Capital Management LP | 1,810,000 | $6,643,000 | 0.42% |